Bain Capital LP is raising a S$460 million ($340 million) loan to back its purchase of Blackstone Inc.’s Singapore-based ...
The Australia-based startup gets seed funding to enhance product management tools, facilitating idea tracking and roadmap ...
Bain Capital, Newlight Partners and Morgan Stanley Private Credit, part of Morgan Stanley, invested in the Overland Park insurance brokerage company (NYSE: SLQT). SelectQuote announced the investment ...
Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...
From new VPs to fresh project managers, see who’s been hired, promoted and honored: It’s our weekly Personnel File roundup.
Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous ...
Virgin Australia’s owners will resume the search for a new CEO following the withdrawal of front-runner Paul Jones after ...
Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Mitsubishi Chemical, a Japanese corporation has agreed to sell its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, to U.S. private equity firm Bain Capital, according to Reuters on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results